Concepedia

Cost of Schizophrenia to UK Society

Julian F. Guest, Ron F. Cookson

PharmacoEconomics · 1999 · 84 citations · 32 references

Concepts

PharmacyPharmacoeconomicsPsychiatryCost-effectiveness AnalysisCost-utility AnalysisMental Health PolicyDirect Medical CostsHealthcare Cost AnalysisMental HealthMental IllnessSchizophrenia Spectrum DisordersDisease Cost Of IllnessEconomic Burden Of IllnessMental Health Care Out-of-pocket Costs

References

32

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

Gary D. Tollefson, Charles M. Beasley, P.V. Tran et al. · American Journal of Psychiatry · 1997 · 901 citations

Medicine, Pharmacotherapy, Psychiatry +17

A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients

Guy Chouinard, B. Jones, Gary Remington et al. · Journal of Clinical Psychopharmacology · 1993 · 881 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Cost of Relapse in Schizophrenia

Peter J. Weiden, Mark Olfson · Schizophrenia Bulletin · 1995 · 675 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +17

Mortality and Causes of Death in First Admitted Schizophrenic Patients

Preben Bo Mortensen, Knud Juel · The British Journal of Psychiatry · 1993 · 414 citations

Medicine, Psychiatry, Adult Psychiatry +10

The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics

Michael Shepherd, D. C. Watt, Ian R. H. Falloon et al. · Psychological Medicine Monograph Supplement · 1989 · 352 citations

Medicine, Psychiatry, Psychology +13